3500亿市值药企赴港敲钟,折价发行半日股价涨超30%

投资时报
23 May

目前,恒瑞医药(600276)有90多个自主创新产品正在临床开发,约400项临床试验在国内外开展,这些项目均对资金有着庞大需求5月23日,本周继宁德时代(300750)(300750.SZ、03750.HK)后,A股医药巨头江苏恒瑞医药股份有限公司(下称恒瑞医药,600276.SH、01276.HK)也正式登陆港交所上市,成为在“A+H”两地上市的本土药企。投资时间网、标点财经研究员注意到,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10